{
  "id": 16892445,
  "title": "Aoxin Q&M gets SGX’s nod for mainboard move",
  "url": "https://urgent.news/2026/10/28/aoxin-q-m-gets-sgxs-nod-for-mainboard-move",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-28T11:59:05.000Z",
  "source": {
    "name": "The Business Times - Singapore",
    "slug": "the-business-times-singapore",
    "url": "https://www.businesstimes.com.sg/singapore/aoxin-qm-gets-sgxs-nod-mainboard-move"
  },
  "original_language": "en",
  "account": "Singapore's Aoxin Q&M dental healthcare services provider secured in-principle approval from the Singapore Exchange to move its listing from the Catalist bourse to the mainboard, according to a report on Tuesday (Oct 27). The company disclosed an 87.2% drop in net profit for its half year ended June 30, 2023, to 0.351 million yuan (US$0.526 million), compared to 2.7 million yuan in the same period last year. Revenue for the same period declined by 12.1% to 76.4 million yuan from 86.8 million yuan the previous year, primarily due to lower patient volumes, reduced average billing per patient, and decreased sales of dental equipment to government hospitals. However, the company's dental laboratory services operations in Singapore showed improved performance. Aoxin Q&M also announced a proposed acquisition of a 100% stake in a dental group in central China, valued at 150 million yuan, to expand its footprint in China. The company comprises two business segments: a network of nearly 30 dental clinics with over 80 dentists, and medical device technology development, wholesale, and retail of Class I and II medical devices. The stock ended at S$0.163, up 4.5% after the announcement.",
  "summary": "The dental group’s net profit sank 87.2% for its first half year",
  "key_points": [
    "Aoxin Q&M granted in-principle approval to move listing from Catalist to SGX mainboard",
    "Company reports 87.2% drop in net profit to 0.351 million yuan for H1 2023",
    "Aoxin Q&M proposes 100% stake acquisition in Chinese dental group valued at 150 million yuan"
  ],
  "editors_take": "Upgrading to the mainboard signals a push for greater prestige and capital access even as the dental provider navigates declining profits and seeks growth through Chinese acquisitions.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}